Scarica l'app Stockscreener
73.02
0.30%
-0.22
Dopo l'orario di chiusura:
72.71
-0.31
-0.42%
Vaxcyte Inc Borsa (PCVX) Ultime notizie
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Smartleaf Asset Management LLC - Defense World
US Bancorp DE Has $408,000 Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Learn to Evaluate (PCVX) using the Charts - Stock Traders Daily
Vaxcyte’s SVP Mikhail Eydelman sells shares worth $353,699 By Investing.com - Investing.com Australia
Insider Sell: Vaxcyte Inc's COO Jim Wassil Sells 3,000 Shares - GuruFocus.com
Mutual of America Capital Management LLC Lowers Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Bank of New York Mellon Corp Boosts Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Vaxcyte’s SVP Mikhail Eydelman sells shares worth $353,699 - Investing.com
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Truist Financial Corp - Defense World
Vaxcyte COO Jim Wassil sells $586,165 in stock By Investing.com - Investing.com Australia
Vaxcyte COO Jim Wassil sells $586,165 in stock - Investing.com India
Vaxcyte, Inc. (PCVX): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey
10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey
Vaxcyte phase II PCV valve to open shortly, Pfizer sizers alert - BioWorld Online
Mizuho maintains Vaxcyte stock Outperform rating, $163 target - Investing.com India
Sanctuary Advisors LLC Boosts Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
(PCVX) Trading Report - Stock Traders Daily
Research Analysts Offer Predictions for Vaxcyte Q1 Earnings - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Handelsbanken Fonder AB - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by New York State Common Retirement Fund - Defense World
Q1 Earnings Estimate for Vaxcyte Issued By Leerink Partnrs - Defense World
Guggenheim Reiterates "Buy" Rating for Vaxcyte (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) Releases Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Vaxcyte's (PCVX) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Biotech Alert: Searches spiking for these stocks today - TipRanks
Vaxcyte’s Promising Prospects and Strategic Engagements Justify Buy Rating - TipRanks
Vaxcyte’s Earnings Call Highlights Strong Position and Future Growth - TipRanks
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure - BioProcess Insider
Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com
Why Vaxcyte, Inc. (PCVX) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds - Insider Monkey
Buy Rating for Vaxcyte Driven by Anticipated Positive Phase 2 Data and Undervalued Stock Potential - TipRanks
Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2024 Earnings Call Transcript - Insider Monkey
Vaxcyte Inc (PCVX) Q4 2024 Earnings Call Highlights: Strong Fina - GuruFocus.com
Vaxcyte Advances Vaccine Pipeline with Strong Financial Backing - TipRanks
Vaxcyte Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Vaxcyte Q4 2024 sees stock dip after earnings - Investing.com
10 Best Vaccine Stocks to Buy According to Hedge Funds - Insider Monkey
Vaxcyte 2024 Loss Narrows -February 25, 2025 at 05:22 pm EST - Marketscreener.com
Vaxcyte, Inc. SEC 10-K Report - TradingView
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Can Vaxcyte's $3.1B War Chest Revolutionize the Pneumococcal Vaccine Market? - StockTitan
Vaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to Analysts - Insider Monkey
What's Driving the Market Sentiment Around Vaxcyte? - Benzinga
Vaxcyte’s Promising Growth in the PCV Market: Analyst Recommends Buy Rating - TipRanks
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
BTIG maintains Vaxcyte stock Buy rating, $160 target By Investing.com - Investing.com Canada
Vaxcyte’s Promising Vaccine Developments and Strong Buy Rating Backed by Robust Clinical Trials and DCF Valuation - TipRanks
15 Stocks That Will Go to The Moon According to Analysts - Insider Monkey
Rhumbline Advisers Buys 7,711 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Vaxcyte (PCVX) Expected to Announce Earnings on Tuesday - Defense World
Vaxcyte (PCVX) to Release Earnings on Tuesday - Armenian Reporter
Vaxcyte, Inc. (NASDAQ:PCVX) CFO Andrew Guggenhime Sells 8,000 Shares - MarketBeat
TimesSquare Capital Management LLC Has $33.86 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) & Tourmaline Bio (NASDAQ:TRML) Financial Review - Defense World
Vaxcyte Inc to Host Earnings Call - ACCESS Newswire
Vaxcyte president and CFO sells $670,822 in stock By Investing.com - Investing.com South Africa
State of New Jersey Common Pension Fund D Purchases 5,427 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte president and CFO sells $670,822 in stock - Investing.com India
1.39%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):